Why it was recalled
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Product description
Paclitaxel Semi-Synthetic active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Lot numbers, UPCs & expiration codes
All lots repackaged and distributed between 01/05/12 to 02/12/15
Where it was sold
Nationwide to compounding pharmacies and research organizations.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-829-2015
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Nov 14, 2014
- FDA report date
- Apr 29, 2015
- Quantity
- 10 grams
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Attix Pharmaceuticals
Original FDA data
Every field from FDA enforcement report D-829-2015, exactly as published.
Show all FDA fields
- City
- Toronto
- Status
- Terminated
- Country
- Canada
- Event ID
- 70452
- Address
- 184 Front St E
- Address (line 2)
- unit 801
- Code information
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Report date
- Apr 29, 2015
- Product type
- Drugs
- Recall number
- D-829-2015
- Classification
- Class II
- Recalling firm
- Attix Pharmaceuticals
- Product quantity
- 10 grams
- Termination date
- Oct 7, 2015
- Reason for recall
- Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Paclitaxel Semi-Synthetic active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
- Distribution pattern
- Nationwide to compounding pharmacies and research organizations.
- Recall initiation date
- Nov 14, 2014
- Initial firm notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Center classification date
- Apr 20, 2015